{
    "2018-10-11": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Abbvie settles Humira patent disputes with Novartis unit",
                "features": {
                    "keywords": [
                        "Abbvie",
                        "Humira",
                        "patent",
                        "disputes",
                        "Novartis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "CLASS ACTION UPDATE for ABBV, MGTI and SFIX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",
                "features": {
                    "keywords": [
                        "CLASS ACTION",
                        "ABBV",
                        "MGTI",
                        "SFIX",
                        "Levi & Korsinsky"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Sandoz, AbbVie Announce Global Resolution Of Humira Patent Disputes",
                "features": {
                    "keywords": [
                        "Sandoz",
                        "AbbVie",
                        "Humira",
                        "patent",
                        "disputes"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",
                "features": {
                    "keywords": [
                        "SHAREHOLDER",
                        "Schall Law Firm",
                        "Class Action",
                        "Lawsuit",
                        "AbbVie"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie stock ticks higher as Humira patent dispute with Novartis resolved",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "stock",
                        "ticks higher",
                        "Humira",
                        "patent",
                        "dispute",
                        "Novartis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Can biotech thrive in a highrise? One developer discovers that it can",
                "features": {
                    "keywords": [
                        "biotech",
                        "highrise",
                        "developer"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "real estate",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Announces Global Resolution of HUMIRAÂ® (adalimumab) Patent Disputes with Sandoz",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "HUMIRA",
                        "patent",
                        "disputes",
                        "Sandoz"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "SHAREHOLDER ALERT: TRCO USAT MCHP COCP ABBV ALNY MGTI CHGG ADNT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines",
                "features": {
                    "keywords": [
                        "SHAREHOLDER ALERT",
                        "TRCO",
                        "USAT",
                        "MCHP",
                        "COCP",
                        "ABBV",
                        "ALNY",
                        "MGTI",
                        "CHGG",
                        "ADNT",
                        "Law Offices",
                        "Vincent Wong",
                        "Class Action"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2018",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}